Document is current
Any future updates will be listed below
-
Authors
Majzner, Robbie G. https://orcid.org/0000-0001-6969-8011
Ramakrishna, Sneha
Yeom, Kristen W. https://orcid.org/0000-0001-9860-3368
Patel, Shabnum
Chinnasamy, Harshini
Schultz, Liora M.
Richards, Rebecca M.
Jiang, Li
Barsan, Valentin
Mancusi, Rebecca https://orcid.org/0000-0002-4809-5569
Geraghty, Anna C.
Good, Zinaida https://orcid.org/0000-0003-2343-5771
Mochizuki, Aaron Y. https://orcid.org/0000-0003-1073-916X
Gillespie, Shawn M.
Toland, Angus Martin Shaw
Mahdi, Jasia
Reschke, Agnes
Nie, Esther H.
Chau, Isabelle J.
Rotiroti, Maria Caterina
Mount, Christopher W.
Baggott, Christina
Mavroukakis, Sharon
Egeler, Emily
Moon, Jennifer
Erickson, Courtney
Green, Sean
Kunicki, Michael https://orcid.org/0000-0001-6630-6289
Fujimoto, Michelle
Ehlinger, Zach
Reynolds, Warren
Kurra, Sreevidya
Warren, Katherine E.
Prabhu, Snehit
Vogel, Hannes
Rasmussen, Lindsey
Cornell, Timothy T.
Partap, Sonia
Fisher, Paul G. https://orcid.org/0000-0002-1196-1590
Campen, Cynthia J. https://orcid.org/0000-0002-3519-1375
Filbin, Mariella G.
Grant, Gerald
Sahaf, Bita
Davis, Kara L. https://orcid.org/0000-0002-7182-2592
Feldman, Steven A.
Mackall, Crystal L. https://orcid.org/0000-0001-6323-4304
Monje, Michelle https://orcid.org/0000-0002-3547-237X
- License Information
-
More Information
Article History
Received: 2 August 2021
Accepted: 28 January 2022
First Online: 7 February 2022
Competing interests
: Stanford University is in the process of applying for a patent application covering treatment of H3K27M-mutated gliomas with GD2-CAR T cells that lists M.M., C.L.M., R.G.M and C.W.M. as inventors. C.L.M. is a cofounder and holds equity in Lyell Immunopharma and Syncopation Life Sciences, which are developing CAR-based therapies, Red Tree Venture Capital, Ensme and Mammoth and consults for Lyell, Syncopation, Red Tree, NeoImmune Tech, Apricity, Nektar, Immatics, Ensoma and Mammoth. R.G.M. is a cofounder of and holds equity in Syncopation Life Sciences; he is also a consultant for Lyell Immunopharma, Syncopation Life Sciences, NKarta, Gamma Delta Therapeutics, Aptorum Group, Illumina Radiopharmaceuticals, ImmunAI, Arovella Therapeutics and Zai Lab. M.M. is on the scientific advisory board for Cygnal Therapeutics.
